PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Divisions of General Internal Medicine and Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States.\', \'Divisions of General Internal Medicine and Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States. Electronic address: Razonable.raymund@mayo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1386-6532(21)00293-610.1016/j.jcv.2021.105026
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 34775142
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34775142>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34775142>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all